SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-022536
Filing Date
2019-11-08
Accepted
2019-11-08 15:01:23
Documents
1
Group Members
NEIL WOODFORD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO SCHEDULE 13G sc13g1119a6woodford_theravan.htm SC 13G/A 72911
  Complete submission text file 0001213900-19-022536.txt   74567
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88552 | Film No.: 191203752
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN
Business Address 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN 00 44 1865809023
Woodford Investment Management Ltd (Filed by) CIK: 0001634557 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A